Q9Y5T5 (UBP16_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 118.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Ubiquitin carboxyl-terminal hydrolase 16 EC=3.4.19.12 Alternative name(s): Deubiquitinating enzyme 16 Ubiquitin thioesterase 16 Ubiquitin-processing protease UBP-M Ubiquitin-specific-processing protease 16 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 823 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Specifically deubiquitinates histone H2A, a specific tag for epigenetic transcriptional repression, thereby acting as a coactivator. Deubiquitination of histone H2A is a prerequisite for subsequent phosphorylation at 'Ser-10' of histone H3, and is required for chromosome segregation when cells enter into mitosis. Regulates Hox gene expression via histone H2A deubiquitination. Prefers nucleosomal substrates. Does not deubiquitinate histone H2B. Ref.1 Ref.9 Ref.10 |
| Catalytic activity | Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal). Ref.10 |
| Subunit structure | Homotetramer. Ref.10 |
| Subcellular location | |
| Tissue specificity | Present in all the tissues examined including fetal brain, lung, liver, kidney, and adult heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Ref.1 |
| Domain | The UBP-type zinc finger binds 3 zinc ions that form a pair of cross-braced ring fingers encapsulated within a third zinc finger in the primary structure. It recognizes the C-terminal tail of free ubiquitin. |
| Post-translational modification | Phosphorylated at the onset of mitosis and dephosphorylated during the metaphase/anaphase transition. The phosphorylated form of the protein is also enzymatically active. Ref.1 |
| Involvement in disease | A chromosomal aberration involving USP16 is a cause of Chronic myelomonocytic leukemia. Inversion inv21 (q21;q22) with RUNX1/AML1. |
| Sequence similarities | Belongs to the peptidase C19 family. USP16 subfamily. Contains 1 UBP-type zinc finger. |
| Sequence caution | The sequence AAG39290.1 differs from that shown. Reason: Erroneous initiation. The sequence BAG51175.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9Y5T5-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9Y5T5-2) The sequence of this isoform differs from the canonical sequence as follows: 150-150: Missing. | ||||||
| Isoform 3 (identifier: Q9Y5T5-3) The sequence of this isoform differs from the canonical sequence as follows: 1-20: MGKKRTKGKTVPIDDSSETL → MGSVAV 150-150: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q9Y5T5-4) The sequence of this isoform differs from the canonical sequence as follows: 1-310: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 5 (identifier: Q9Y5T5-5) The sequence of this isoform differs from the canonical sequence as follows: 394-823: SGKKSVNDKN...AYLLFYERIL → VRLLNLFYSSRFFFL |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 823 | 823 | Ubiquitin carboxyl-terminal hydrolase 16 | PRO_0000080643 | |||||||||||||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||||||||||||
| Zinc finger | 60 – 125 | 66 | UBP-type | ||||||||||||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||||||||||||
| Active site | 205 | 1 | Nucleophile | ||||||||||||||||||||||||||||||||||
| Active site | 758 | 1 | Proton acceptor By similarity | ||||||||||||||||||||||||||||||||||
| Metal binding | 24 | 1 | Zinc 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 26 | 1 | Zinc 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 48 | 1 | Zinc 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 51 | 1 | Zinc 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 74 | 1 | Zinc 3 | ||||||||||||||||||||||||||||||||||
| Metal binding | 77 | 1 | Zinc 3 | ||||||||||||||||||||||||||||||||||
| Metal binding | 82 | 1 | Zinc 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 88 | 1 | Zinc 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 90 | 1 | Zinc 2 | ||||||||||||||||||||||||||||||||||
| Metal binding | 94 | 1 | Zinc 3 | ||||||||||||||||||||||||||||||||||
| Metal binding | 103 | 1 | Zinc 3 | ||||||||||||||||||||||||||||||||||
| Metal binding | 116 | 1 | Zinc 1 | ||||||||||||||||||||||||||||||||||
| Metal binding | 119 | 1 | Zinc 1 | ||||||||||||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||||||||||||
| Modified residue | 415 | 1 | Phosphoserine Ref.12 Ref.16 | ||||||||||||||||||||||||||||||||||
| Modified residue | 552 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 | ||||||||||||||||||||||||||||||||||
| Modified residue | 554 | 1 | Phosphothreonine Ref.14 | ||||||||||||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 310 | 310 | Missing in isoform 4. | VSP_036713 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 1 – 20 | 20 | MGKKR…SSETL → MGSVAV in isoform 3. | VSP_036714 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 150 | 1 | Missing in isoform 2 and isoform 3. | VSP_036715 | |||||||||||||||||||||||||||||||||
| Alternative sequence | 394 – 823 | 430 | SGKKS…YERIL → VRLLNLFYSSRFFFL in isoform 5. | VSP_036716 | |||||||||||||||||||||||||||||||||
| Natural variant | 141 | 1 | Q → H. Ref.3 Ref.7 Corresponds to variant rs2274802 [ dbSNP | Ensembl ]. | VAR_020388 | |||||||||||||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||||||||||||
| Mutagenesis | 205 | 1 | C → S: Loss of enzyme activity. Ref.1 Ref.9 Ref.10 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 141 | 1 | Q → E in AAG39290. Ref.8 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 297 | 1 | Q → R in BAG51175. Ref.3 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 348 | 1 | K → E in BAD96604. Ref.4 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 350 | 1 | S → P in BAD96401. Ref.4 | ||||||||||||||||||||||||||||||||||
| Sequence conflict | 480 – 481 | 2 | EY → DN in AAH30777. Ref.7 | ||||||||||||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||||||||||||
| Helix | 27 – 30 | 4 | |||||||||||||||||||||||||||||||||||
| Helix | 33 – 40 | 8 | |||||||||||||||||||||||||||||||||||
| Beta strand | 45 – 47 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 49 – 52 | 4 | |||||||||||||||||||||||||||||||||||
| Turn | 63 – 65 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 71 – 74 | 4 | |||||||||||||||||||||||||||||||||||
| Turn | 75 – 77 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 80 – 82 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 86 – 88 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 90 – 96 | 7 | |||||||||||||||||||||||||||||||||||
| Beta strand | 105 – 108 | 4 | |||||||||||||||||||||||||||||||||||
| Turn | 109 – 111 | 3 | |||||||||||||||||||||||||||||||||||
| Beta strand | 114 – 116 | 3 | |||||||||||||||||||||||||||||||||||
| Turn | 117 – 120 | 4 | |||||||||||||||||||||||||||||||||||
| Beta strand | 121 – 123 | 3 | |||||||||||||||||||||||||||||||||||
| Helix | 130 – 142 | 13 | |||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A mutant deubiquitinating enzyme (Ubp-M) associates with mitotic chromosomes and blocks cell division." Cai S.-Y., Babbitt R.W., Marchesi V.T. Proc. Natl. Acad. Sci. U.S.A. 96:2828-2833(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, PHOSPHORYLATION, MUTAGENESIS OF CYS-205. |
| [2] | Grimbert P., Pawlak A., Sahali D. Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5). |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4), VARIANT HIS-141. Tissue: Amygdala, Teratocarcinoma and Testis. |
| [4] | Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S. Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Brain and Liver. |
| [5] | "The DNA sequence of human chromosome 21." Hattori M., Fujiyama A., Taylor T.D., Watanabe H., Yada T., Park H.-S., Toyoda A., Ishii K., Totoki Y., Choi D.-K., Groner Y., Soeda E., Ohki M., Takagi T., Sakaki Y., Taudien S., Blechschmidt K., Polley A. Yaspo M.-L.Nature 405:311-319(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [7] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), VARIANT HIS-141. Tissue: Testis. |
| [8] | Liu B., Liu Y.Q., Wang X.Y., Zhao B., Sheng H., Zhao X.W., Liu S., Xu Y.Y., Ye J., Song L., Gao Y., Zhang C.L., Zhang J., Wei Y.J., Cao H.Q., Zhao Y., Liu L.S., Ding J.F. Hui R.T.Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 139-823. Tissue: Aorta. |
| [9] | "Caspase-dependent deubiquitination of monoubiquitinated nucleosomal histone H2A induced by diverse apoptogenic stimuli." Mimnaugh E.G., Kayastha G., McGovern N.B., Hwang S.G., Marcu M.G., Trepel J., Cai S.-Y., Marchesi V.T., Neckers L. Cell Death Differ. 8:1182-1196(2001) [PubMed] [Europe PMC] [Abstract] Cited for: PRELIMINARY FUNCTION, MUTAGENESIS OF CYS-205. |
| [10] | "Regulation of cell cycle progression and gene expression by H2A deubiquitination." Joo H.-Y., Zhai L., Yang C., Nie S., Erdjument-Bromage H., Tempst P., Chang C., Wang H. Nature 449:1068-1072(2007) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, IDENTIFICATION BY MASS SPECTROMETRY, SUBUNIT, SUBCELLULAR LOCATION, MUTAGENESIS OF CYS-205. |
| [11] | "Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes." Gelsi-Boyer V., Trouplin V., Adelaide J., Aceto N., Remy V., Pinson S., Houdayer C., Arnoulet C., Sainty D., Bentires-Alj M., Olschwang S., Vey N., Mozziconacci M.-J., Birnbaum D., Chaffanet M. BMC Cancer 8:299-299(2008) [PubMed] [Europe PMC] [Abstract] Cited for: CHROMOSOMAL REARRANGEMENT. |
| [12] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415 AND SER-552, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-552, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [14] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-552 AND THR-554, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [16] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-415, MASS SPECTROMETRY. |
| [17] | "Solution structure of the Ubp-M BUZ domain, a highly specific protein module that recognizes the C-terminal tail of free ubiquitin." Pai M.-T., Tzeng S.-R., Kovacs J.J., Keaton M.A., Li S.S.-C., Yao T.-P., Zhou P. J. Mol. Biol. 370:290-302(2007) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 22-143, ZINC-BINDING. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF126736 mRNA. Translation: AAD20949.1. AY333928 mRNA. Translation: AAR13293.1. AK023247 mRNA. Translation: BAG51175.1. Different initiation. AK302247 mRNA. Translation: BAG63599.1. AK294284 mRNA. Translation: BAG57569.1. AK222681 mRNA. Translation: BAD96401.1. AK222884 mRNA. Translation: BAD96604.1. AL163249 Genomic DNA. Translation: CAB90432.1. AF129075 Genomic DNA. No translation available. CH471079 Genomic DNA. Translation: EAX09927.1. CH471079 Genomic DNA. Translation: EAX09929.1. BC030777 mRNA. Translation: AAH30777.1. AF113219 mRNA. Translation: AAG39290.1. Different initiation. | ||||||||||||
| IPI | IPI00001780. IPI00428464. IPI00792644. IPI00923398. IPI00923450. | ||||||||||||
| RefSeq | NP_001001992.1. NM_001001992.1. NP_001027582.1. NM_001032410.1. NP_006438.1. NM_006447.2. | ||||||||||||
| UniGene | Hs.99819. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9Y5T5. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q9Y5T5. 4 interactions. | ||||||||||||
Protein family/group databases | |||||||||||||
| MEROPS | C19.021. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9Y5T5. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 6686071. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q9Y5T5. | ||||||||||||
| PRIDE | Q9Y5T5. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 10600. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000334352; ENSP00000334808; ENSG00000156256. ENST00000399975; ENSP00000382857; ENSG00000156256. ENST00000399976; ENSP00000382858; ENSG00000156256. | ||||||||||||
| GeneID | 10600. | ||||||||||||
| KEGG | hsa:10600. | ||||||||||||
| UCSC | uc002ymw.3. human. uc002ymx.3. human. uc011acm.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 10600. | ||||||||||||
| GeneCards | GC21P030396. | ||||||||||||
| H-InvDB | HIX0023011. | ||||||||||||
| HGNC | HGNC:12614. USP16. | ||||||||||||
| HPA | HPA021140. | ||||||||||||
| MIM | 604735. gene. | ||||||||||||
| neXtProt | NX_Q9Y5T5. | ||||||||||||
| PharmGKB | PA37240. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG5560. | ||||||||||||
| HOVERGEN | HBG062704. | ||||||||||||
| InParanoid | Q9Y5T5. | ||||||||||||
| KO | K11844. | ||||||||||||
| OMA | CKNVAEE. | ||||||||||||
| PhylomeDB | Q9Y5T5. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9Y5T5. | ||||||||||||
| Bgee | Q9Y5T5. | ||||||||||||
| CleanEx | HS_USP16. | ||||||||||||
| Genevestigator | Q9Y5T5. | ||||||||||||
| GermOnline | ENSG00000156256. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| Gene3D | 3.30.40.10. 1 hit. | ||||||||||||
| InterPro | IPR018200. Pept_C19ubi-hydrolase_C_CS. IPR001394. Peptidase_C19. IPR013083. Znf_RING/FYVE/PHD. IPR001607. Znf_UBP. [Graphical view] | ||||||||||||
| Pfam | PF00443. UCH. 1 hit. PF02148. zf-UBP. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS00972. UCH_2_1. 1 hit. PS00973. UCH_2_2. 1 hit. PS50235. UCH_2_3. 1 hit. PS50271. ZF_UBP. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | USP16. human. | ||||||||||||
| EvolutionaryTrace | Q9Y5T5. | ||||||||||||
| GenomeRNAi | 10600. | ||||||||||||
| NextBio | 40254. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | UBP16_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y5T5 Secondary accession number(s): A8MU43 Q9H3E6 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Peptidase families Classification of peptidase families and list of entries |
| Human chromosome 21 Human chromosome 21: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
